Energy Metabolism in Conformational Diseases

Biosimulation in Drug Development

Volumn , Issue , 2008, Pages 233-257

  Ovádi, Judit ^a   Orosz, Ferenc ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Biosimulation; Brain energy source; Conformational diseases; Drug metabolism; Energy metabolism; Glycolytic enzymes; Impair energy metabolism; Microcompartmentation; Neurodegenerative proteins; Post translational modifications; Triosephosphate isomerase deficiency; Unfolded misfolded proteins

Indexed keywords

EID: 51749093777     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527622672.ch8     Document Type: Chapter

References (116)

1. Chih, C. P., Lipton, P., Roberts, E. L. J.: Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci.. 2001, 24:573-578.
2. Pellerin, L., Magistretti, P. J.: Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl Acad. Sci. USA 1994, 91:10625-10629.
3. Pellerin, L., Pellegri, G., Bittar, P. G., Charnay, Y., Bouras, C., Martin, J. L., Stella, N., Magistretti, P. J.: Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 1998, 20:291-299.
4. Gjedde, A., Marrett, S., Vafaee, M.: Oxidative and nonoxidative metabolism of excited neurons and astrocytes. J. Cereb. Blood Flow Metab. 2002, 22:1-14.
5. Pellerin, L., Magistretti, P. J.: How to balance the brain energy budget while spending glucose differently. J. Physiol. 2003, 546:325.
6. Fillenz, M.: The role of lactate in brain metabolism Neurochem. Int. 2005, 47:413-417.
7. Aubert, A., Costalat, R., Magistretti, P. J., Pellerin, L.: Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc. Natl. Acad. Sci. USA 2005, 102:16448-16453.
8. Hu, Y., Wilson, G. S.: A temporary local energy pool coupled to neuronal activity: fluctuations of extracellular lactate levels in rat brain monitored with rapidresponse enzyme-based sensor. J. Neurochem. 1997, 69:1484-1490.
9. Pellerin, L., Magistretti, P. J.: Let there be (NADH) light. Science 2004, 305:50-52.
10. Prichard, J., Rothman, D., Novotny, E., Petroff, O., Kuwabara, T., Avison, M., Howseman, A., Hanstock, C., Shulman, R.: Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. USA 1991, 88:5829-5831.
11. Frahm, J., Kruger, G., Merboldt, K. D., Kleinschmidt, A.: Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man.Magn. Reson. Med. 1996, 35:143-148.
12. Mangia, S., Garreffa, G., Bianciardi, M., Giove, F., Di Salle, F., Maraviglia, B.: The aerobic brain: lactate decrease at the onset of neural activity. Neuroscience 2003, 118:7-10.
13. Kasischke, K. A., Vishwasrao, H. D., Fisher, P. J., Zipfel, W. R.: Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 2004, 305:99-103.
14. Berg, J. M., Tymoczko, J. L., Stryer, L.: Biochemistry, 5th edn. Freeman, New York, 2002.
15. Sims, N. R., Blass, J. P., Murphy, C., Bowen, D. M., Neary, D.: Phosphofructokinase activity in the brain in Alzheimer's disease. Ann Neurol. 1987, 21:509-510.
16. Bigl, M., Brückner, M. K., Arendt, T., Bigl, V., Eschirch, K.: Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J. Neural Transm. 1999, 106:499-511.
17. Sorbi, S., Mortilla, M., Piacentini, S., Tonini, S., Amaducci, L.: Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients. Neurosci. Lett. 1990, 117:165-168.
18. Bigl, M., Bleyl, A. D., Zedlick, D., Arendt, T., Bigl, V., Eschrich, K.: Changes of activity and isozyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease. J. Neurochem. 1996, 67:1164-1171.
19. Dunker, A. K., Brown, C. J., Lawson, J., Iakoucheva, L. M., Obradovic, Z.: Intrinsic disorder and protein function. Biochemistry 2002, 41:6573-6582.
20. Wright, P. E., Dyson, H. J.: Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm J. Mol. Biol. 1999, 293:321-331.
21. Johnston, J. A., Ward, C. L., Kopito, R. R.: Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 1998, 143:1883-1898.
22. Ovádi, J., Orosz, F., Lehotzky, A.: What is the biological significance of the brainspecific tubulin-polymerization promoting protein (TPPP/p25)? IUBMB Life. 2005, 57:765-768.
23. Muchowski, P., Wacker, J. L.: Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 2005, 6:11-22.
24. Bossy-Wetzel, E., Schwarzenbacher, R., Lipton, S. A.: Molecular pathways to neurodegeneration. Nat. Med. 2004, 10[Suppl]S2-S9.
25. Vannucci, R. C., Vannucci, S. J.: Glucose metabolism in the developing brain. Semin. Perinatol. 2000, 24:107-115.
26. Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N., Heston, L., Moore, A., Schlageter, N., Larson, S., Rapoport, S. I.: Positron emission tomography in Alzheimer's disease. Neurology 1986, 36:879-887.
27. Tucek, S., Ricny, J., Dolezal, V.: Advances in the biology of cholinergic neurons. Adv. Neurol. 1990, 51:109-115.
28. Hoshi, M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T., Imahori, K.: Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease. J. Biol. Chem. 1997, 272:2038-2041.
29. Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., Imahori, K.: Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. Proc. Natl. Acad. Sci. USA 1996, 93:2719-2723.
30. Erecinska, M., Silver, I. A.: ATP and brain function. J. Cereb. Blood Flow Metab. 1989, 9:2-19.
31. Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., Butterfield, D. A.: Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biol. Med. 2002, 33:562-571.
32. Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., Butterfield, D. A.: Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 2003, 85:1394-1401.
33. Hoyer, S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv. Exp. Med. Biol. 2004, 541:135-152.
34. Guo, J. P., Arai, T., Miklossy, J., McGeer, P. L.: Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2006, 103:1953-1958.
35. Tabaton, M.: Research advances in the biology of Alzheimer's disease. Clin. Geriatr. Med. 1994, 10:249-255.
36. Meier-Ruge, W. A., Bertoni-Freddari, C.: Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type. Ann. NY Acad. Sci. 1997, 826:229-241.
37. Schulze, H., Schuyler, A., Stuber, D., Dobeli, H., Langen, H., Huber, G.: Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J. Neurochem. 1993, 60:1915-1922.
38. Ovádi, J., Orosz, F., Hollán, S.: Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations Mol. Cell. Biochem. 2004, 256/257:83-93.
39. Mazzola, J. L., Sirover, M. A.: Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J. Neurochem. 2001, 76:442-449.
40. Barinaga, M.: An intriguing new lead on Huntington's disease Science. 1996, 271:1233-1234.
41. Roses, A. D.: From genes to mechanisms to therapies: Lessons to be learned from neurological disorders. Nat. Med. 1996, 2:267-269.
42. Chuang, D. M., Ishitani, R.: A role for GAPDH in apoptosis and neurodegeneration. Nat. Med. 1996, 2:609-610.
43. Meier-Ruge, W., Bertoni-Freddari, C.: The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease. Rev. Neurosci. 1996, 7:1-19.
44. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., Bates, G. P.: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotypes in transgenic mice. Cell 1996, 87:493-506.
45. Burke, J. R., Enghild, J. J., Martin, M. E., Jou, Y.-S., Myers, R. M., Roses, A. D., Vance, J. M., Strittmatter, W. J.: Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med. 1996, 2:347-350.
46. Cooper, A. J., Sheu, K. F., Burke, J. R., Strittmatter, W. J., Blass, J. P.: Glyceraldehyde-3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts. Dev. Neurosci. 1998, 20:462-468.
47. Sharp, A.H., Lowv, S. J., Li, S. H., Li, X. J., Bao, J., Waster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., Hedreen, J., Sisodia, S., Snyder, S.H., Dawson, T.M., Ryugo, D. K., Ross, C. A.: Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995, 14:1065-1074.
48. Kovács, G. G., László, L., Kovács, J., Jensen, P. H., Lindersson, E., Botond, G., Molnár, T., Perczel, A., Hudecz, F., Mez?o, G., Erdei, A., Tirián, L., Lehotzky, A., Gelpi, E., Budka, H., Ovádi, J.: Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol. Dis. 2004, 17:155-162.
49. Tsuchiya, K., Tajima, H., Kuwae, T., Takeshima, T., Nakano, T., Tanaka, M., Sunaga, K., Fukuhara, Y., Nakashima, K., Ohama, E., Mochizuki, H., Mizuno, Y., Katsube, N., Ishitani, R.: Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions. Eur. J. Neurosci. 2005, 21:317-326.
50. Oláh, J., T?okési, N., Vincze, O., Horváth, I., Lehotzky, A., Erdei, A., Szájli, E., Medzihradszky, K. F., Orosz, F., Kovács, G. G., Ovádi, J.: Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies. FEBS Lett. 2006, 580:5807-5814.
51. Tatton, N. A.: Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 2000, 166:29-43.
52. Lindersson, E., Beedholm, R., Hojrup P, Moos, T., Gai, W., Hendil, K. B., Jensen, P. H.: Proteasomal inhibition by alphasynuclein filaments and oligomers. J. Biol. Chem. 2004, 279:12924-12934.
53. Lindersson, E., Lundvig, D., Petersen, C., Madsen, P., Nyengaard, J. R., Hojrup, P., Moos, T., Otzen, D., Gai, W. P., Blumbergs, P. C., Jensen, P. H.: p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alphasynuclein in alpha-synucleinopathies. J. Biol. Chem. 2005, 280:5703-5715.
54. Ross, C. A., Poirier, M. A.: Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10:S10-S17.
55. Orosz, F., Kovács, G. G., Lehotzky, A., Oláh, J., Vincze, O., Ovádi, J.: TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments. Biol. Cell 2004, 96:701-711.
56. Iijima, T., Mishima, T., Akagawa, K., Iwao, Y.: Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 2003, 993:140-145.
57. Butterfield, D. A., Castegna, A., Lauderback, C. M., J. Drake, J.: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging. 2002, 23:655-664.
58. Lovell, M. A., Xie, C., Markesbery, W. R.: Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging. 2001, 22:187-194.
59. Good, P. F., Hsu, A., Werner, P., Perl, D. P., Olanow, C. W.: Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 1998, 57:338-342.
60. Cookson, M. R., Shaw, P. J.: Oxidative stress and motor neurone disease. Brain Pathol. 1999, 9:165-186.
61. Walker, L. M., York, J. L., Imam, S. Z., Ali, S. F., Muldrew, K. L., Mayeux, P. R.: Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol. Sci. 2001, 63:143-148.
62. Radi, R.: Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 2004, 101:4003-4008.
63. Coma, M., Guix, F. X., Uribesalgo, I., Espuna, G., Solé, M., Andreu, D. F., Munoz, J.: Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination. Brain Res. 2005, 128:1613-1621.
64. Butterfield, D. A., Bush, A. I.: Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol. Aging 2004, 25:563-568.
65. Huie, R., Padmaja, S.: The reaction of NO with superoxide. Free Radic. Res. Commun. 1993, 18:195-199.
66. Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., Markesbery, W. R., Butterfield, D. A.: Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD. Neurobiol. Aging 2006, 27:1564-1576.
67. Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., Butterfield, D. A.: Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol. Dis. 2006, 22:76-87.
68. Castegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., Butterfield, D. A.: Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate. J. Neurochem. 2002, 71:1524-1532.
69. Verbeek, M. M., De Jong, D., Kremer, H. P.: Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann. Clin. Biochem. 2003, 40:25-40.
70. Meier-Ruge, W., Iwangoff, P., Reichlmeier, K.: Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 1984, 3:161-165.
71. Iwangoff, P., Armbruster, R., Enz, A., Meier-Ruge, W.: Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech. Ageing Dev. 1980, 14:203-209.
72. Cumming, R. C., Schubert, D.: Amyloidbeta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J. 2005, 19:2060-2062.
73. Rapoport, S. I., Horwitz, B., Grady, C. L., Haxby, J. V., DeCarli, C., Schapiro, M. B.: Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography. Adv. Exp. Med. Biol. 1991, 291:231-248.
74. Vanhanen, M., Soininen, H.: Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr. Opin. Neurol. 1998, 11:673-677.
75. Bonnet, R., Pavlovic, S., Lehmann, J., Rommelspacher, H.: The strong inhibition of TPI by the natural β-carbolines may explain their neurotoxic actions. Neuroscience 2004, 127:443-453.
76. Kuhn, W., Muller, T., Gerlach, M., Sofic, E., Fuchs, G., Heye, N., Prautsch, R., Przuntek, H.: Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients. J. Neural. Transm. 1996, 103:1435-1440.
77. Hollán, S., Magócsi, M., Fodor, E., Horányi, M., Harsányi, V., Farkas, T.: Search for the pathogenesis of the differing phenotype in two compound heterozygote Hungarian brothers with the same genotypic triosephosphate isomerase deficiency. Proc. Natl. Acad. Sci. USA 1997, 94:10362-10366.
78. Schneider, A. S.: Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Bailliére's Clin. Haematol. 2000, 13:119-140.
79. Orosz, F., Oláh, J., Alvarez, M., Keseru, G. M., Szabó, B., Wágner, G., Kovári, Z., Horányi, M., Baróti, K., Martial, J. A., Hollán, S., Ovádi, J.: Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency. Blood 2001, 98:3106-3112.
80. Oláh, J., Orosz, F., Keseru, G. M., Kovári, Z., Kovács, J., Hollán, S., Ovádi, J.: Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease. Biochem. Soc. Trans. 2002, 30:30-38.
81. Oláh, J., Orosz, F., Puskás, L. G., Hackler, L., Horányi, M., Polgár, L., Hollán, S., Ovádi, J.: Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels. Biochem. J. 2005, 392:675-683.
82. Schuster, R., Holzhütter, H.-G.: Use of mathematical models for predicting the metabolic effect of large-scale enzyme activity alterations. Application to enzyme deficiences of red blood cells. Eur. J. Biochem. 1995, 229:403-418.
83. Heinrich, R., Rapoport, S. M., Rapoport, T. A.: Metabolic regulation and mathematical models. Prog. Biophys. Mol. Biol. 1977, 32:1-82.
84. Martinov, M. V., Plotnikov, A. G., Vitvitsky, V. M., Ataullakhanov, F. I.: Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia. Biochim. Biophys. Acta 2000, 1474:75-87.
85. Hollán, S., Fujii, H., Hirono, A., Hirono, K., Karro, H., Miwa, S., Harsányi, V., Gyódi, E., Inselt-Kovács, M.: Hereditary triosephosphate isomerase (TPI) deficiency: two severaly affected brothers one with and one without neurological symptoms. Hum. Genet. 1993, 92:486-490.
86. Orosz, F., Wágner, G., Liliom, K., Kovács, J., Baróti, K., Horányi, M., Farkas, T., Hollán, S., Ovádi, J.: Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. Proc. Natl. Acad. Sci. USA 2000, 97:1026-1031.
87. Gibson, A. M., Edwardson, J. A., McDermott, J. R.: Post mortem levels of some brain peptidases in Alzheimer's disease: reduction in proline endopeptidase activity in cerebral cortex. Neurosci. Res. Commun. 1991, 9:73-81.
88. Mantle, D., Falkous, G., Ishiura, S., Blanchard, P. J., Perry, E. K.: Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clin. Chim. Acta 1996, 249:129-139.
89. Ahmed, N., Battah, S., Karachalias, N., Babaei-Jadidi, R., Horányi, M., Baróti, K., Hollán, S., Thornalley, P. J.: Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim. Biophys. Acta 2003, 1639:121-132.
90. Shah, J. V., Cleveland, D. W.: Slow axonal transport: fast motors in the slow lane. Curr. Opin.Cell Biol. 2002, 14:58-62.
91. Black, M. M., Lasek, R. J.: Slow components of axonal transport: two cytoskeletal networks. J. Cell Biol. 1980 86:616-623.
92. Wojtas, K., Slepecky, N., von Kalm, L., Sullivan, D.: Flight muscle function in Drosophila requires colocalization of glycolytic enzymes. Mol. Biol. Cell 1997, 8:1665-1675.
93. Sullivan, D. T., MacIntyre, R., Fuda, N., Fiori, J., Barrilla, J., Ramizel, L.: Analysis of glycolytic enzyme co-localization in Drosophila flight muscle. J. Exp. Biol. 2003, 206:2031-2038.
94. Lehotzky, A., Pálfia, Z., Kovács, J., Molnár, A., Ovádi, J.: Ligand-modulated cross-bridging of microtubules by phosphofructokinase. Biochem. Biophys. Res. Commun. 1994, 204:585-591.
95. Lehotzky, A., Telegdi, M., Liliom, K., Ovádi, J.: Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects. J. Biol. Chem. 1993, 268:10888-10894.
96. Vértessy, B. G., Kovács, J., Ovádi, J.: Specific characteristics of phosphofructokinase-microtubule interaction. FEBS Lett. 1996, 379:191-195.
97. McNay, E. C., Fries, T. M., Gold, P. E.: Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc. Natl. Acad. Sci. USA 2000, 97:2881-2885.
98. Waagepetersen, H. S., Sonnewald, U., Larsson, O. M., Schousboe, A.: Multiple compartments with different metabolic characteristics are involved in biosynthesis of intracellular and released glutamine and citrate in astrocytes. Glia 2001, 35:246-252.
99. Sickmann, H. M., Schousboe, A., Fosgerau, K., Waagepetersen, S.: Compartmentation of lactate originating from glycogen and glucose in cultured astrocytes. Neurochem. Res. 2005, 30:1295-1304.
100. Li, X., Yokono, K., Okada, Y.: Phosphofructokinase, a glycolytic regulatory enzyme has a crucial role for maintenance of synaptic activity in guinea pig hippocampal slices. Neurosci. Lett. 2000, 294:81-84.
101. Ikemoto, A., Bole, D., Ueda, T.: Glycolysis and glutamate accumulation into synaptic vesicle. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J. Biol. Chem. 2003, 278:5929-5940.
102. Gorini, A., D'Angelo, A., Villa, R. F.: Energy metabolism of synaptosomal subpopulations from different neuronal systems of rat hippocampus: effect of L-acetylcarnitine administration in vivo. Neurochem. Res. 1999, 24:617-624.
103. Walsh, M. J., Kuruc, N.: The postsynaptic density: constituent and associated proteins characterized by electrophoresis, immunoblotting, and peptide sequencing. J. Neurochem. 1992, 59:667-678.
104. Jordan, B. A., Fernholz, B. D., Boussac, M., Xu, C., Grigorean, G., Ziff, E. B., Neubert, T. A.: Identification and verification of novel rodent postsynaptic density proteins. Mol. Cell Proteomics 2004, 3:857-871.
105. Li, K. W., Hornshaw, M. P., Van der Schors, R. C., Watson, R., Tate, S., Casetta, B., Jimenez, C. R., Gouwenberg, Y., Gundelfinger, E. D., Smalla, K.-H., Smit, A. B.: Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J. Biol. Chem. 2004, 279:987-1002.
106. Peng, J., Kim, M. J., Cheng, D., Duong, D. M., Gygi, S. P., Sheng, M.: Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem. 2004, 279:21003-21011.
107. Yoshimura, Y., Yamauchi, Y., Shinkawa, T., Taoka, M., Donai, H., Takahashi, N., Isobe, T., Yamauchi, T.: Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem. 2004, 88:759-768.
108. Cheng, D., Hoogenraad, C. C., Rush, J., Ramm, E., Schlager, M. A., Duong, D. M., Xu, P., Rukshan, S., Hanfelt, J., Nakagawa, T., Sheng, M., Peng, J.: Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell. Proteomics 2006, 5:1158-1170.
109. Collins, M. O., Yu, L., Coba, M. P., Husi, H., Campuzano, I., Blackstock, W. P., Choudhary, J. S., Grant, S. G.: Pro teomic analysis of in vivo phosphorylated synaptic proteins. J. Biol. Chem. 2005, 280:5972-5982.
110. Collins, M. O., Husi, H., Yu, L., Brandon, J. M., Anderson, C. N. G., Blackstock, W. P., Choudhary, J. S., Grant, S. G. N.: Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J. Neurochem. 2006, 97[Suppl. 1]:16-23.
111. Siekevitz, P.: The postsynaptic density: a possible role in long-lasting effects in the central nervous system. Proc. Natl. Acad. Sci. USA 1985, 82:3494-3498.
112. Rogalski-Wilk, A. A., Cohen, R. S.: Glyceraldehyde-3-phosphate dehydrogenase activity and F-actin associations in synaptosomes and postsynaptic densities of porcine cerebral cortex. Cell Mol. Neurobiol. 1997, 17:51-70.
113. Wu, K., Aoki, C., Elste, A., Rogalski-Wilk, A., Siekevitz, P.: The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide. Proc. Natl Acad. Sci. USA 1997, 94:13273-13278.
114. Schurr, A., Payne, R. S., Miller, J. J., Rigor, B. M.: Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia. Brain Res. 1997, 774:221-224.
115. Srere, P. A.: The metabolon. Trends Biochem. Sci. 1985, 10:109-110.
116. Zanella, A., Izzo, C., Meola, G., Mariani, M., Colotti, M. T., Silani, V., Pellegata, G.: Metabolic impairment and membrane abnormality in red cells from Huntington's disease. J. Neurol. Sci. 1980, 47:93-103.